These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 6546849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human osteoblasts in culture metabolize both 1 alpha, 25-dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones.
    Siu-Caldera ML, Zou L, Ehrlich MG, Schwartz ER, Ishizuka S, Reddy GS.
    Endocrinology; 1995 Oct; 136(10):4195-203. PubMed ID: 7664636
    [Abstract] [Full Text] [Related]

  • 3. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F, Mayer E, Norman AW.
    Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
    [Abstract] [Full Text] [Related]

  • 4. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
    Harada M, Miyahara T, Miyata M, Tomita I, Okayachi H, Ikemoto Y, Higuchi S, Otomo S, Kozuka H, Ikekawa N.
    Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
    [Abstract] [Full Text] [Related]

  • 5. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
    Harada M, Miyahara T, Miyata M, Komiyama H, Sugure A, Ikemoto Y, Kondo S, Takamura T, Higuchi S, Otomo S.
    Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
    [Abstract] [Full Text] [Related]

  • 6. 1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells.
    Ishizuka S, Kurihara N, Hakeda S, Maeda N, Ikeda K, Kumegawa M, Norman AW.
    Endocrinology; 1988 Aug; 123(2):781-6. PubMed ID: 3396507
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological activity of (22E,25R)- and (22,25S)-22-dehydro- 1 alpha,25-dihydroxy-26-methylvitamin D3.
    Hara N, Eguchi T, Ikekawa N, Ishizuka S, Sato J.
    J Steroid Biochem; 1990 May; 35(6):655-64. PubMed ID: 2163469
    [Abstract] [Full Text] [Related]

  • 8. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro.
    Ishizuka S, Sumitani K, Hiura K, Kawata T, Okawa M, Hakeda Y, Kumegawa M.
    Endocrinology; 1990 Aug; 127(2):695-701. PubMed ID: 2373050
    [Abstract] [Full Text] [Related]

  • 9. Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
    Sato K, Nishii Y, Woodiel FN, Raisz LG.
    Bone; 1993 Aug; 14(1):47-51. PubMed ID: 8443002
    [Abstract] [Full Text] [Related]

  • 10. Calcioic acid: In vivo detection and quantification of the terminal C24-oxidation product of 25-hydroxyvitamin D3 and related intermediates in serum of mice treated with 24,25-dihydroxyvitamin D3.
    Kaufmann M, Martineau C, Arabian A, Traynor M, St-Arnaud R, Jones G.
    J Steroid Biochem Mol Biol; 2019 Apr; 188():23-28. PubMed ID: 30553931
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria.
    Harada M, Miyahara T, Kajita-Kondo S, Kozakai A, Higuchi S, Otomo S, Kozuka H.
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):183-93. PubMed ID: 7881867
    [Abstract] [Full Text] [Related]

  • 13. Effects of 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites on bone metabolism in vivo and in vitro.
    Kumegawa M, Ishizuka S, Sumitani K, Hiura K, Kawata T, Okawa M, Hakeda Y.
    Contrib Nephrol; 1991 Nov; 91():109-15. PubMed ID: 1666030
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
    Miyahara T, Harada M, Kozakai A, Matsumoto M, Hashimoto K, Inoue H, Yoda K, Nakatsu T, Kajita S, Yamazaki R, Higuchi S, Kozuka H, Nemoto N.
    J Nutr Sci Vitaminol (Tokyo); 1999 Jun; 45(3):239-49. PubMed ID: 10524344
    [Abstract] [Full Text] [Related]

  • 16. Biological activity assessment of the vitamin D metabolites 1,25-dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3.
    Mayer E, Bishop JE, Ohnuma N, Norman AW.
    Arch Biochem Biophys; 1983 Jul 15; 224(2):671-6. PubMed ID: 6307158
    [Abstract] [Full Text] [Related]

  • 17. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.
    Cross HS, Farsoudi KH, Peterlik M.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan 15; 347(1):105-10. PubMed ID: 8446178
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.